Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

STRYKER CORP (SYK) Stock Forecast 2025 - AI Price Prediction & Analysis

STRYKER CORP (SYK) AI Stock Price Forecast & Investment Analysis

STRYKER CORP Stock Price Chart and Technical Analysis

Loading STRYKER CORP interactive price chart and technical analysis...

STRYKER CORP (SYK) - Comprehensive Stock Analysis & Investment Research

Deep dive into STRYKER CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about STRYKER CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For STRYKER CORP: STRYKER CORP operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

STRYKER CORP (Stock Symbol: SYK) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 51000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing STRYKER CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STRYKER CORP: With $23818M in annual revenue and 16.3% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $23818 million generating a 16.3% net profit margin .

Market Capitalization: $140684 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 14.1% - Above-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for STRYKER CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For STRYKER CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for STRYKER CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: STRYKER CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For STRYKER CORP: Strong free cash flow generation demonstrates exceptional operational efficiency.

STRYKER CORP strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $2453 million annually, complemented by impressive 49.6% year-over-year cash flow growth.

The company maintains a healthy 63.6% gross margin, indicating strong pricing power and operational efficiency.

STRYKER CORP (SYK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for STRYKER CORP stock analysis.

Loading STRYKER CORP comprehensive fundamental analysis and insider trading data...

Deep dive into STRYKER CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if STRYKER CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For STRYKER CORP: With a P/E ratio of 42.00, the market highly values future growth prospects.

P/E Ratio 42.00x
P/B Ratio 11.99x
Market Cap $140684M
EPS $7.65
Book Value/Share $31.36
Revenue/Share $9.28
FCF/Share $5.93
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently STRYKER CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For STRYKER CORP: An ROE of 14.1% shows good shareholder value creation.

ROE 14.1%
ROA 5.8%
ROIC 7.2%
Gross Margin 63.6%
Operating Margin 19.9%
Net Margin 16.3%
EBT Margin 13.2%
Tax Rate 12.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess STRYKER CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For STRYKER CORP: A current ratio of 1.98 shows adequate liquidity.

Current Ratio 1.98x
Quick Ratio 1.03x
D/E Ratio 0.92x
Financial Leverage 2.40x
Interest Coverage 45.6x
Working Capital $4666M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal STRYKER CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For STRYKER CORP: Free cash flow of $2453M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $3014M
Free Cash Flow $2453M
Capital Spending $-561M
OCF Growth YoY 49.6%
FCF Growth YoY 80.9%
FCF/Sales 14.1%
CapEx/Sales 3.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively STRYKER CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For STRYKER CORP: An asset turnover of 0.50x suggests room for improvement in asset utilization.

Asset Turnover 0.50x
Receivables Turnover 6.2x
Inventory Turnover 1.8x
Fixed Assets Turnover 6.3x
Days Sales Outstanding 59 days
Days Inventory 205 days
Payables Period 54 days
Cash Conversion Cycle 209 days
Understanding Financial Statement Data

What these metrics mean: Key figures from STRYKER CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For STRYKER CORP: With annual revenue of $23818M, STRYKER CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $23818M
R&D Expense $1458M
SG&A Expense $38M
Cost of Goods Sold $1232M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 24%
Cash & Short-term Investments 4%
Total Liabilities 58%
Short-term Debt 1%
Accounts Receivable 8%
Inventory 10%
Dividend & Shareholder Information
Dividends Per Share $1.55
Payout Ratio 0.2%
Shares Outstanding 374M
Growth Metrics (YoY)
EPS Growth 2.4%

Latest STRYKER CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting STRYKER CORP (SYK) stock price and investment outlook.

📰 We are currently updating our news feed for STRYKER CORP. Check back soon for the latest market analysis and company updates.

STRYKER CORP Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of STRYKER CORP against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $24M x 2.8x
AEMD Unlock Forecast - 30 Days FREE Trial $3M -0.1x 0.7x
AFIB Unlock Forecast - 30 Days FREE Trial $0M 0.0x -0.4x
ALUR Unlock Forecast - 30 Days FREE Trial $17M -0.4x -0.3x
AMIX Unlock Forecast - 30 Days FREE Trial $4M x 0.5x
ANGO Unlock Forecast - 30 Days FREE Trial $447M -1.4x 2.4x
ANIK Unlock Forecast - 30 Days FREE Trial $129M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1823M -198.2x 4.3x
APYX Unlock Forecast - 30 Days FREE Trial $76M -3.5x 10.5x
ARAY Unlock Forecast - 30 Days FREE Trial $138M -9.9x 2.8x
ATEC Unlock Forecast - 30 Days FREE Trial $2277M -7.4x 95.8x
ATRC Unlock Forecast - 30 Days FREE Trial $1808M -39.6x 3.9x
AVGR Unlock Forecast - 30 Days FREE Trial $2M -1.3x 0.4x
AVHHL Unlock Forecast - 30 Days FREE Trial $24M x x
BAX Unlock Forecast - 30 Days FREE Trial $12541M -94.9x 1.7x
BBNX Unlock Forecast - 30 Days FREE Trial $1142M x 3.8x
BDX Unlock Forecast - 30 Days FREE Trial $53939M 34.0x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $46M -5.7x 11.0x
BEATW Unlock Forecast - 30 Days FREE Trial $15M x 3.2x
BJDX Unlock Forecast - 30 Days FREE Trial $2M -0.5x 0.4x
BLAC Unlock Forecast - 30 Days FREE Trial $12M x -2.1x
BLACR Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
BLACU Unlock Forecast - 30 Days FREE Trial $14M x -2.4x
BLACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
BSX Unlock Forecast - 30 Days FREE Trial $153377M 61.2x 6.8x
BTCY Unlock Forecast - 30 Days FREE Trial $10M -2.7x -0.1x
BVS Unlock Forecast - 30 Days FREE Trial $617M -18.3x 3.8x
CARL Unlock Forecast - 30 Days FREE Trial $-18M x x
CERS Unlock Forecast - 30 Days FREE Trial $235M -13.8x 4.2x
CLPT Unlock Forecast - 30 Days FREE Trial $314M -23.5x 15.9x
CODX Unlock Forecast - 30 Days FREE Trial $11M -0.7x 0.3x
CTCX Unlock Forecast - 30 Days FREE Trial $5M -0.2x -1.2x
CTCXW Unlock Forecast - 30 Days FREE Trial $1M x -0.2x
CTSO Unlock Forecast - 30 Days FREE Trial $64M -1.8x 4.4x
CVRX Unlock Forecast - 30 Days FREE Trial $208M -5.5x 3.6x
DCTH Unlock Forecast - 30 Days FREE Trial $465M 208.2x 4.4x
DHAI Unlock Forecast - 30 Days FREE Trial $10M x -0.3x
DHAIW Unlock Forecast - 30 Days FREE Trial $1M x 0.0x
DRIO Unlock Forecast - 30 Days FREE Trial $30M 0.6x 0.4x
DRTS Unlock Forecast - 30 Days FREE Trial $306M x 3.5x
DXCM Unlock Forecast - 30 Days FREE Trial $31083M 54.4x 12.1x
EBRCZ Unlock Forecast - 30 Days FREE Trial $246M x 5.0x
EMBC Unlock Forecast - 30 Days FREE Trial $572M 15.8x -0.8x
FEMY Unlock Forecast - 30 Days FREE Trial $12M -1.4x 8.1x
FNA Unlock Forecast - 30 Days FREE Trial $1098M -15.4x 8.4x
FOFA Unlock Forecast - 30 Days FREE Trial $8M x 13.6x
GCTK Unlock Forecast - 30 Days FREE Trial $2M 0.9x -0.5x
GIPL Unlock Forecast - 30 Days FREE Trial $5M x 27.9x
GKOS Unlock Forecast - 30 Days FREE Trial $5008M -46.3x 6.5x
GMED Unlock Forecast - 30 Days FREE Trial $8236M 23.1x 1.9x
GUTS Unlock Forecast - 30 Days FREE Trial $88M x 13.8x
HAE Unlock Forecast - 30 Days FREE Trial $3541M 26.1x 4.3x
HRGN Unlock Forecast - 30 Days FREE Trial $28M x 36.7x
IART Unlock Forecast - 30 Days FREE Trial $1160M 200.2x 1.1x
ICAD Unlock Forecast - 30 Days FREE Trial $106M -3.1x 3.5x
ICCM Unlock Forecast - 30 Days FREE Trial $60M x 20.9x
ICU Unlock Forecast - 30 Days FREE Trial $8M -1.1x 13.3x
ICUCW Unlock Forecast - 30 Days FREE Trial $0M x -0.1x
ICUI Unlock Forecast - 30 Days FREE Trial $3248M -49.8x 1.6x
IDXG Unlock Forecast - 30 Days FREE Trial $22M 4.2x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $30M x 6.8x
IINNW Unlock Forecast - 30 Days FREE Trial $8M x 2.0x
INBS Unlock Forecast - 30 Days FREE Trial $11M -0.3x 3.6x
INFU Unlock Forecast - 30 Days FREE Trial $216M 42.6x 4.0x
INSP Unlock Forecast - 30 Days FREE Trial $2411M 45.4x 3.6x
IRMD Unlock Forecast - 30 Days FREE Trial $914M 44.3x 9.7x
IRTC Unlock Forecast - 30 Days FREE Trial $5812M -20.2x 56.1x
IVF Unlock Forecast - 30 Days FREE Trial $1M x 0.3x
KIDS Unlock Forecast - 30 Days FREE Trial $488M -20.7x 1.4x
KMTS Unlock Forecast - 30 Days FREE Trial $1121M x x
KRMD Unlock Forecast - 30 Days FREE Trial $188M -19.8x 11.4x
LMAT Unlock Forecast - 30 Days FREE Trial $0M 58.7x 0.0x
LNSR Unlock Forecast - 30 Days FREE Trial $58M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $140M -0.6x 17.7x
LUNG Unlock Forecast - 30 Days FREE Trial $71M -4.3x 1.0x
LYRA Unlock Forecast - 30 Days FREE Trial $524M -0.1x 135.2x
MBOT Unlock Forecast - 30 Days FREE Trial $92M -1.3x 3.2x
MCAG Unlock Forecast - 30 Days FREE Trial $22M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $21M x -9.9x
MDAI Unlock Forecast - 30 Days FREE Trial $69M -1.3x -42.3x
MDAIW Unlock Forecast - 30 Days FREE Trial $9M x -2.1x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.8x 13.4x
MDXG Unlock Forecast - 30 Days FREE Trial $1041M 32.4x 4.8x
MGRM Unlock Forecast - 30 Days FREE Trial $206M -10.7x 23.9x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $87134M 22.1x 20.3x
MMSI Unlock Forecast - 30 Days FREE Trial $5498M 46.2x 3.7x
MODD Unlock Forecast - 30 Days FREE Trial $38M -2.1x 2.2x
NARI Unlock Forecast - 30 Days FREE Trial $4677M -51.9x 10.8x
NAYA Unlock Forecast - 30 Days FREE Trial $2M -0.3x 0.2x
NEPH Unlock Forecast - 30 Days FREE Trial $39M -20.3x 2.0x
NMTC Unlock Forecast - 30 Days FREE Trial $40M -1.7x 4.8x
NPCE Unlock Forecast - 30 Days FREE Trial $322M -10.4x 16.5x
NSPR Unlock Forecast - 30 Days FREE Trial $122M -4.3x 6.0x
NURO Unlock Forecast - 30 Days FREE Trial $9M -0.5x 0.7x
NVAC Unlock Forecast - 30 Days FREE Trial $69M 84.3x -13.6x
NVACR Unlock Forecast - 30 Days FREE Trial $1M x -0.1x
NVACW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
NVCR Unlock Forecast - 30 Days FREE Trial $1358M -20.8x 3.9x
NVNO Unlock Forecast - 30 Days FREE Trial $87M -2.0x 2.3x
NVRO Unlock Forecast - 30 Days FREE Trial $221M -2.1x 1.0x
NXGL Unlock Forecast - 30 Days FREE Trial $18M -6.8x 4.0x
NXGLW Unlock Forecast - 30 Days FREE Trial $3M x 0.7x
OBIO Unlock Forecast - 30 Days FREE Trial $118M -3.4x 2.0x
OFIX Unlock Forecast - 30 Days FREE Trial $580M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $18M x 0.2x
OSUR Unlock Forecast - 30 Days FREE Trial $241M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $20M 0.3x 0.5x
PAVMZ Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
PDEX Unlock Forecast - 30 Days FREE Trial $128M 14.3x 3.5x
PEN Unlock Forecast - 30 Days FREE Trial $10839M 73.4x 8.4x
PETV Unlock Forecast - 30 Days FREE Trial $18M -1.4x 12.0x
PLSE Unlock Forecast - 30 Days FREE Trial $1016M -2.6x 8.6x
PODD Unlock Forecast - 30 Days FREE Trial $24144M 102.3x 16.5x
PRCT Unlock Forecast - 30 Days FREE Trial $2080M -45.4x 5.4x
PROF Unlock Forecast - 30 Days FREE Trial $124M x 3.2x
PSTV Unlock Forecast - 30 Days FREE Trial $12M -0.3x -0.5x
PYPD Unlock Forecast - 30 Days FREE Trial $54M x 2.6x
RCEL Unlock Forecast - 30 Days FREE Trial $111M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $47M x 17.4x
RMD Unlock Forecast - 30 Days FREE Trial $39802M 28.4x 6.7x
RSMDF Unlock Forecast - 30 Days FREE Trial $2450M 1.8x 0.4x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $24M -0.9x 0.3x
SGHT Unlock Forecast - 30 Days FREE Trial $192M -3.7x 2.7x
SIBN Unlock Forecast - 30 Days FREE Trial $675M -14.3x 4.0x
SINT Unlock Forecast - 30 Days FREE Trial $7M -0.5x 1.1x
SKIN Unlock Forecast - 30 Days FREE Trial $288M -1.8x 3.9x
SNOA Unlock Forecast - 30 Days FREE Trial $8M -5.6x 1.9x
SNWV Unlock Forecast - 30 Days FREE Trial $308M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12913M 34.0x 3.5x
SRDX Unlock Forecast - 30 Days FREE Trial $432M -79.3x 3.9x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSII Unlock Forecast - 30 Days FREE Trial $1535M x 37.9x
SSKN Unlock Forecast - 30 Days FREE Trial $7M -8.0x 24.1x
STIM Unlock Forecast - 30 Days FREE Trial $248M -1.0x 9.1x
STME Unlock Forecast - 30 Days FREE Trial $12M x x
STSS Unlock Forecast - 30 Days FREE Trial $10M -2.5x 0.7x
STSSW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
SYK Unlock Forecast - 30 Days FREE Trial $140684M 42.0x 12.0x
TCMD Unlock Forecast - 30 Days FREE Trial $319M 21.1x 1.6x
TELA Unlock Forecast - 30 Days FREE Trial $72M -1.8x 7.9x
TFX Unlock Forecast - 30 Days FREE Trial $5978M 31.2x 1.4x
TLSI Unlock Forecast - 30 Days FREE Trial $191M -3.6x -5.6x
TLSIW Unlock Forecast - 30 Days FREE Trial $66M x -1.9x
TMCI Unlock Forecast - 30 Days FREE Trial $628M -7.5x 6.0x
TNDM Unlock Forecast - 30 Days FREE Trial $829M -17.1x 6.2x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.3x
TNONW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
TTOO Unlock Forecast - 30 Days FREE Trial $4M 0.0x -0.3x
UFPT Unlock Forecast - 30 Days FREE Trial $1757M 44.7x 4.9x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $208M 16.6x 1.8x
VERO Unlock Forecast - 30 Days FREE Trial $5M 0.0x 2.2x
VTAK Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.3x
VVOS Unlock Forecast - 30 Days FREE Trial $21M -0.5x 2.8x
WST Unlock Forecast - 30 Days FREE Trial $18455M 37.8x 6.3x
XAIR Unlock Forecast - 30 Days FREE Trial $303M -0.3x 22.3x
XTNT Unlock Forecast - 30 Days FREE Trial $93M -478.8x 1.9x

Frequently Asked Questions - STRYKER CORP Stock Forecast

How accurate are STRYKER CORP stock predictions?

Our AI model demonstrates 40% historical accuracy for SYK predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence STRYKER CORP stock price forecasts?

Our analysis considers STRYKER CORP's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is STRYKER CORP a good investment in 2025?

Based on our AI analysis, STRYKER CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are STRYKER CORP forecasts updated?

STRYKER CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced STRYKER CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for STRYKER CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...